Syncom Formulation (India) Ltd (NSE:SYNCOMF) Share Price

Company Profile

Business description
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.
Contact
207, Saket Nagar
Near Saket Club
IndoreMP452018
IND
T: +91 7312560458
https://www.sfil.in
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
2,122

Recommended

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.

Matthew Dolgin, CFA | 20 October 2025

Shares plunged over 17% after reporting disappointing results.

Angus Hewitt, CFA | 20 October 2025

Growth outlook solid, but upside more than priced in.

Shaun Ler | 19 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,390.10	16.40	0.17%
CAC 40	8,225.73	19.66	0.24%
DAX 40	24,264.29	5.49	0.02%
Dow JONES (US)	46,830.55	123.97	0.27%
FTSE 100	9,407.22	3.65	0.04%
HKSE	26,027.55	168.72	0.65%
NASDAQ	22,939.73	50.81	-0.22%
Nikkei 225	49,316.06	130.56	0.27%
NZX 50 Index	13,377.85	32.89	0.25%
S&P 500	6,732.13	3.00	-0.04%
S&P/ASX 200	9,094.70	18.80	0.21%
SSE Composite Index	3,916.33	52.44	1.36%